V. Fink

发表

Decision-making in HIV clinical trials: a study with patients enrolled in antiretroviral trials.

D. Moriña, M. Feijoo-Cid, A. Rivero-Santana, 2020, Gaceta sanitaria.

Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean

P. Cahn, V. Fink, J. Pape, 2015, Journal of the International AIDS Society.

Benznidazole Treatment of Chagasic Encephalitis in Pregnant Woman with AIDS

V. Fink, J. Altcheh, A. Schijman, 2013, Emerging Infectious Diseases.

Improved Diagnosis of Strongyloides stercoralis Using Recombinant Antigen-Based Serologies in a Community-Wide Study in Northern Argentina

Rogan Lee, T. Nutman, V. Fink, 2010, Clinical and Vaccine Immunology.

HIV Drug Therapy in the Americas 16–18 April 2015, Mexico City, Mexico

M. Lederman, D. Podzamczer, D. Kuritzkes, 2015, Journal of the International AIDS Society.

The effect of non-AIDS-defining cancers on people living with HIV.

A. Mazul, K. Sigel, V. Fink, 2021, The Lancet. Oncology.

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

Sally S Bebawy, Richard D Moore, J. Margolick, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America

V. Fink, B. Grinsztejn, B. Shepherd, 2016, PloS one.

Cancer in HIV-Infected Persons From the Caribbean, Central and South America

D. Masys, P. Cahn, C. César, 2011, Journal of acquired immune deficiency syndromes.

Antiretroviral therapy and Kaposi’s sarcoma trends and outcomes among adults with HIV in Latin America

V. Fink, E. Gotuzzo, C. Jenkins, 2021, Journal of the International AIDS Society.

Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America

P. Cahn, V. Fink, C. Jenkins, 2018, Infectious Agents and Cancer.

Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy

W. Wester, T. Sterling, P. Cahn, 2022, BMC Infectious Diseases.

Impact of HIV-ART on the restoration of Th17 and Treg cells in blood and female genital mucosa

H. Salomón, P. Cahn, V. Fink, 2019, Scientific Reports.

Temporal Trends in Age at HIV Diagnosis in Cohorts in the United States, the Caribbean, and Central and South America

V. Fink, V. Rouzier, P. Luz, 2015, AIDS and Behavior.

Rates and Reasons for Early Change of First HAART in HIV-1-Infected Patients in 7 Sites throughout the Caribbean and Latin America

D. Masys, P. Cahn, V. Fink, 2010, PloS one.

HIV Drug Therapy in the Americas Congress, 13 – 15 June 2013, São Paulo, Brazil

M. Lederman, D. Kuritzkes, K. White, 2013, Journal of the International AIDS Society.

Association between HIV-1 RNA level and CD4 cell count among untreated HIV-infected individuals.

P. Harrigan, B. Yip, R. Hogg, 2009, American journal of public health.

AssociationBetweenHIV-1RNALevelandCD4Cell CountAmongUntreatedHIV-InfectedIndividuals

P. Harrigan, B. Yip, R. Hogg, 2009 .

Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study.

P. Cahn, V. Fink, O. Sued, 2015, The lancet. HIV.

Use of Third Line Antiretroviral Therapy in Latin America

P. Cahn, V. Fink, O. Sued, 2014, PloS one.

Fostemsavir

V. Fink, P. Cahn, Patricia Patterson, 2018, Current Opinion in HIV and AIDS.

Fostemsavir: a new CD4 attachment inhibitor

P. Cahn, V. Fink, P. Patterson, 2018, Current opinion in HIV and AIDS.

The HIV care cascade in Buenos Aires, Argentina: results in a tertiary referral hospital.

P. Cahn, P. Rebeiro, V. Fink, 2016, Revista panamericana de salud publica = Pan American journal of public health.

Retention among transgender women treated with dolutegravir associated with tenofovir/lamivudine or emtricitabine in Argentina: TransViiV study

P. Cahn, V. Fink, O. Sued, 2023, PloS one.

Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries

B. Chi, J. Sterne, K. Anastos, 2013, Journal of acquired immune deficiency syndromes.

Impact of HIV-ART on the restoration of Th17 and Treg cells in blood and female genital mucosa

H. Salomón, P. Cahn, V. Fink, 2019, Scientific Reports.

Clinical-epidemiological features of HIV-infected patients diagnosed at age of 50 years or older

P. Cahn, V. Fink, O. Sued, 2012, Journal of the International AIDS Society.

Treatment as prevention: are Argentinean HIV care providers willing to adopt earlier antiretroviral therapy?

P. Cahn, V. Fink, O. Sued, 2014, AIDS care.

Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America

P. Cahn, V. Fink, C. Jenkins, 2018, Infectious Agents and Cancer.

Oral and anal microbiome from HIV-exposed individuals: role of host-associated factors in taxa composition and metabolic pathways

P. Cahn, V. Fink, O. Sued, 2023, NPJ biofilms and microbiomes.

Exploring the Decision-Making Process of People Living with HIV Enrolled in Antiretroviral Clinical Trials: A Qualitative Study of Decisions Guided by Trust and Emotions.

M. Feijoo-Cid, A. Rivero-Santana, V. Fink, 2023, Health care analysis : HCA : journal of health philosophy and policy.

Use of darunavir and enfuvirtide in a pregnant woman

P. Cahn, V. Fink, O. Sued, 2008, International journal of STD & AIDS.

The effect of protease inhibitor‐based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART‐naïve patients with HIV‐infection

P. Cahn, V. Fink, O. Sued, 2020, HIV medicine.

Service delivery challenges in HIV care during the first year of the COVID‐19 pandemic: results from a site assessment survey across the global IeDEA consortium

L. Diero, F. Dabis, F. Palella, 2022, Journal of the International AIDS Society.

Latin American and the Caribbean Code Against Cancer 1st edition: Infections and cancer.

C. Porras, V. Fink, C. Espina, 2023, Cancer epidemiology.